Positive Voices: National Survey of People with HIV

Not Applicable

Completed

• Conditions: Topic: Infection; Subtopic: Infection (all Subtopics); Disease: Infectious diseases and microbiology; Infections and Infestations; Human immunodeficiency virus [HIV] disease

• Registration Number: ISRCTN63267760
• Lead Sponsor: Public Health England (UK)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2013-10-11
• Last Update Posted: 18 April 2017

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 1366

Inclusion Criteria

Phase 1: Focus Group Discussion & Cognitive Interviews:
1. HIV positive
2. Male and female, aged 18 and over
3. Accessing care at an NHS HIV clinic

Phases 2 & 3: Pilot and Full Survey:
1. HIV positive
2. Male and female, aged 18 and over
3. Accessing care at an NHS HIV clinic
4. Reported to SOPHID in the previous calendar year

Exclusion Criteria

Phase 1: Focus Group Discussion & Cognitive Interviews:
1. Unable to speak English
2. Participant declines audio recording of the discussion (for focus group discussions only)

Phases 2 & 3: Pilot and Full Survey:
Unable to complete online questionnaire due to language or literacy

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Response rates; Timepoints: Which method of incentivising clinics and participants achieves the highest response rate.<br>Assessed at the end of the study. For example, response rates will be calculated by counting the total number of survey responses, the total number of survey invitation slips returned by the clinics, and retrospectively counting the actual number of HIV+ patients who attended during the study period.

Secondary Outcome Measures

Name	Time	Method
1. Assess whether response rates among the various risk groups and age groups are representative of the national HIV population (+/10%).<br>2. Assess key determinants of variation in response rates by risk group, age group, geography, and clinic size.<br><br>Assessed at the end of the study.